Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-06

Clinical Trial Update: Customized TULSA-PRO Ablation Registry

View source ↗

Summary

The Customized TULSA-PRO Ablation Registry (NCT05001477), sponsored by Profound Medical Inc., is currently recruiting for prostate-related conditions including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Profound Medical Inc. | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Status: RECRUITING